Early drug development requires manufacturing of Investigational Medicinal Products (IMP) that comply with Good Manufacturing Practice (GMP) systems and processes. PRA Early Development Services (EDS) provides in-house Chemistry, Manufacturing, and Control (CMC) services, including formulation development and real-time manufacture of subject-ready drug products on-site in PRA’s state-of-the-art GMP facilities.
Accelerated Early Clinical Manufacturing
PRA’s Accelerated Early Clinical Manufacturing services provide on-site IMP development and manufacturing, as well as in-house Quality Control lab…
Early Patient Solutions
We provide the infrastructure, technologies, and expertise required to execute early phase patient studies worldwide.
Hepatic Impairment Studies – Early Patient Solutions
PRA Health Sciences’ Early Patient Solutions (EPS) is an established team of highly experienced Phase I professionals dedicated to early phase…